• Entity registrant name: Concordia International Corp. (CIK: 0001642271)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1642271/000164227118000008/0001642271-18-000008-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1642271/000164227118000008/cxrx-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001642271
  • Open this page in separate window: Click

    • * * *

    Component: (Network and Table)
    Network
    1005000 - Statement - Consolidated Statements of Cash Flows
    (http://concordiarx.com/role/ConsolidatedStatementsOfCashFlows)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Reporting Entity [Axis] 0001642271 (http://www.sec.gov/CIK)
    Statement of cash flows [abstract] Period [Axis]
    2017-01-01 - 2017-12-31
    2016-01-01 - 2016-12-31
    2015-01-01 - 2015-12-31
    Statement of cash flows [abstract]
     
     
     
    Net loss from continuing operations
    (1,590,735,000) 
    (1,314,093,000) 
    (29,425,000) 
    Adjustments to reconcile net loss to net cash flows from operating activities:
     
     
     
    Interest and accretion expense (Notes 14)
    506,794,000  
    300,690,000  
    129,195,000  
    Interest income (Note 13)
    (61,302,000) 
    (21,671,000) 
    (311,000) 
    Depreciation and amortization (Note 8)
    228,387,000  
    184,758,000  
    76,287,000  
    Share based compensation expense (Note 17)
    8,711,000  
    30,753,000  
    16,198,000  
    Non-cash inventory fair value adjustments (Note 7)
    311,000  
    21,412,000  
    33,932,000  
    Fair value (gain) loss (Note 21)
    1,406,000  
    (8,929,000) 
    (99,000) 
    Impairments (Notes 8 & 9)
    1,194,765,000  
    1,132,243,000  
    0  
    Income tax expense (recovery) (Note 12)
    (36,757,000) 
    (34,801,000) 
    (23,064,000) 
    Realized loss on foreign exchange forward contract
    0  
    0  
    5,126,000  
    Fair value (gain) loss on derivative financial instruments (Note 13)
    109,580,000  
    2,620,000  
    0  
    Gain on debt settlement (Note 14)
    (21,188,000) 
    0  
    0  
    Unrealized foreign exchange (gain) loss
    (72,891,000) 
    128,574,000  
    0  
    Contingent consideration paid (Note 21)
    (10,348,000) 
    (4,037,000) 
    0  
    Income taxes paid
    (23,116,000) 
    (20,283,000) 
    (16,220,000) 
    Income tax refunds
    4,933,000  
    0  
    0  
    Other non-cash items
    2,169,000  
    1,177,000  
    338,000  
    Changes in non-cash working capital (Note 27)
    42,440,000  
    6,088,000  
    (67,535,000) 
    Cash flows from operating activities - continuing operations
    283,159,000  
    404,501,000  
    124,422,000  
    Cash flows from operating activities - discontinued operations
    0  
    3,789,000  
    (2,417,000) 
    Net cash flows from operating activities
    283,159,000  
     
    408,290,000  
     
    122,005,000  
     
    Cash flows used in investing activities
     
     
     
    Purchase consideration paid
    0  
    (30,677,000) 
    (3,807,160,000) 
    Purchase of fixed assets and development costs
    (2,469,000) 
    (1,881,000) 
    (2,048,000) 
    Proceeds from sale of assets
    1,108,000  
    0  
    10,000,000  
    Interest earned
    824,000  
    966,000  
    0  
    Net cash flows used in investing activities
    (537,000) 
     
    (31,592,000) 
     
    (3,799,208,000) 
     
    Cash flows (used in) from financing activities
     
     
     
    Proceeds from credit facilities (Note 14)
    0  
    350,000,000  
    4,154,500,000  
    Deferred financing costs paid
    0  
    (20,275,000) 
    (203,032,000) 
    Proceeds from exercise of options
    0  
    84,000  
    6,233,000  
    Repayment of long-term debt (Note 14)
    (57,279,000) 
    (18,193,000) 
    (880,104,000) 
    Proceeds from issuance of common shares
    0  
    0  
    805,140,000  
    Equity issuance costs paid
    0  
    0  
    (21,289,000) 
    Loss on foreign exchange forward contract
    0  
    0  
    (5,126,000) 
    Contingent consideration paid (Note 21)
    (97,420,000) 
    (143,170,000) 
    (4,074,000) 
    Interest paid (Notes 13 & 14)
    (294,297,000) 
    (251,734,000) 
    (42,878,000) 
    Interest received (Note 13)
    76,616,000  
    0  
    0  
    Dividends paid
    0  
    (11,477,000) 
    (10,060,000) 
    Net cash flows (used in) from financing activities
    (372,380,000) 
     
    (94,765,000) 
     
    3,799,310,000  
     
    Net change in cash and cash equivalents
    (89,758,000) 
     
    281,933,000  
     
    122,107,000  
     
    Effects of exchange rate changes on cash and cash equivalents
    18,871,000  
    (39,464,000) 
    (9,429,000) 
    Cash and cash equivalents, beginning of year
    397,917,000  
    155,448,000  
    42,770,000  
    Cash and cash equivalents, end of year
    327,030,000  
     
    397,917,000  
     
    155,448,000